APU
CTIC

Alpine Partners USVI’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Alpine Partners USVI’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-9,002
Closed -$94K – 190
2013
Q2 		$94K Buy
+9,002
New +$106K 0.03% 168

Other funds holding CTIC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Alpine Partners USVI's CTIC Position: Q3 2013 in Review

Alpine Partners USVI sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2013, closing a stake of 9,002 shares — an estimated $94K sold.

Alpine Partners USVI first reported a position in CTIC in Q2 2013 and held it in 1 quarter. The position peaked at $94K in Q2 2013. 67 funds tracked by Wall St. Rank hold CTIC as of Q3 2013.

  • Alpine Partners USVI reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2013 after selling out during the quarter.
  • Alpine Partners USVI sold 9,002 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2013, an estimated $94K.
  • Alpine Partners USVI first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 1 quarter.
  • Alpine Partners USVI's CTI BioPharma Corp. (DE) Common Stock position peaked at $94K in Q2 2013.
  • 67 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2013.

Based on Alpine Partners USVI's 13F filing for Q3 2013, filed 14 Nov 2013.